You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 790 Phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and AS01B in combination with intravenously administered nivolumab

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
790 Phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and AS01B in combination with intravenously administered nivolumab
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to September 2024

AbstractFullPdf
Nov 2022183011
Dec 20227406
Jan 20234403
Feb 20234603
Mar 20234405
Apr 20234202
May 20233401
Jun 20236403
Jul 20232005
Aug 20232206
Sep 20231401
Oct 20233003
Nov 20232803
Dec 20234205
Jan 20242002
Feb 20243803
Mar 20242009
Apr 202432010
May 20242602
Jun 20242803
Jul 20244806
Aug 20242603
Sep 20244808
Total9730103